Table 2.
EOLC4 N=62 |
Non-EOLC N=212 |
EOLC4 vs Non-EOLC (p-value) | |
---|---|---|---|
Median Survival months (range) | 21 (2 – 104) | 32 (2 – 167) | 0.04 |
Age at diagnosis of primary cancer median (range) | 47 (31–71) | 52 (25–88) | 0.003 |
Age at metastatic cancer diagnosis median (range) | 50 (35–74) | 56 (26–89) | 0.001 |
Number of metastatic sites mean (SD) | 3.5 (1.2) | 2.8 (1.3) | 0.0002 |
Total lines of chemotherapy mean (SD) | 4.3 (2.4) | 2.8 (2.3) | <0.0001 |